InspireMD, Inc. (NSPR) Surges: Stock Moves 12.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:11AM CDT
InspireMD, Inc. (NSPR) was a big mover last session, as the company saw its shares rise over 12% on the day.
XENT: 16.78 (+0.48), ATEC: 1.49 (unch), NSPR: 1.79 (-0.11), ANGO: 16.09 (+0.49)
Cepheid Q3 Loss Narrower than Expected, Sales View Upped - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:20AM CDT
Cepheid (CPHD) experienced a solid 15.1% year-over-year growth in revenues of $115.2 million in the third quarter.
ATEC: 1.49 (unch), CPHD: 48.14 (+1.58), ANGO: 16.09 (+0.49)
Why AngioDynamics (ANGO) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:48AM CDT
AngioDynamics is one such company that might be well-positioned for future earnings growth as this firm, which is in the healthcare sector, saw EPS growth of 65.71% last year, and is looking great for this year too
ANGO: 16.09 (+0.49)
Luminex (LMNX) Crumbles: Stock Falls by 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:00AM CDT
Luminex has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for last 24 hours
ATEC: 1.49 (unch), LMNX: 19.72 (+0.25), ANGO: 16.09 (+0.49)
Will AngioDynamics (ANGO) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:20AM CDT
Will AngioDynamics (ANGO) Continue to Surge Higher?
ANGO: 16.09 (+0.49)
Increased Earnings Estimates Seen for AngioDynamics (ANGO): Can It Move Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 7:56AM CDT
AngioDynamics could be an interesting play for investors as the stock has a decent short-term momentum and is seeing solid activity on the earnings estimate revision
ANGO: 16.09 (+0.49)
Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
AUO: 4.00 (+0.14), BCC: 31.91 (+0.68), ACIW: 18.30 (+0.52), BAS: 14.82 (+0.52), ANGO: 16.09 (+0.49)
AngioDynamics (ANGO) Jumps: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:25AM CDT
AngioDynamics (ANGO) was a big mover last session, with shares rising nearly 6% on the day.
ATEC: 1.49 (unch), EW: 105.81 (+3.94), ANGO: 16.09 (+0.49), ERB: 2.76 (-0.01)
Company News for October 13, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 9:10AM CDT
Companies in the News are: HELE,JNPR,ANGO,SYMC
HELE: 60.25 (+1.40), ANGO: 16.09 (+0.49), SYMC: 23.67 (+1.17), JNPR: 20.18 (+0.38)
4 Stocks Rising on Big Volume to Trade for Breakouts
at The Street - Mon Oct 13, 6:53AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
ZUMZ: 32.75 (+1.26), ECOL: 45.48 (+1.02), BABY: 32.25 (+1.04), ANGO: 16.09 (+0.49)
AngioDynamics to be Added to the S&P SmallCap 600 Index
GlobeNewswire - Mon Oct 13, 5:43AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it will be added to the S&P SmallCap 600 Index and the GICS Life & Health Insurance sub-industry index after the close of trading on Monday, October 20, 2014.
ANGO: 16.09 (+0.49)
Tanger Factory Outlet Centers Set to Join the S&P MidCap 400; American Equity Investment Life, AngioDynamics to Join the S&P SmallCap 600
PR Newswire - Fri Oct 10, 4:53PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
AEL: 23.74 (+0.23), URS: 54.20 (unch), BNNY: 45.97 (unch), SKT: 35.05 (+0.54), ACM: 31.55 (+1.15), ANGO: 16.09 (+0.49), GIS: 50.46 (+0.54)
AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:00AM CDT
For fiscal 2015, AngioDynamics Inc. (ANGO) raised its adjusted per share guidance to a range of 65 to 71 cents from the prior expectation of 64 to 70 cents, on the back of stronger than anticipated first-quarter results.
BSX: 12.03 (+0.42), ANGO: 16.09 (+0.49), ERB: 2.76 (-0.01)
AngioDynamics Reports 2015 First Quarter Financial Results
GlobeNewswire - Thu Oct 09, 3:01PM CDT
-- First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million; Sales grew 5%, excluding supply agreement
ANGO: 16.09 (+0.49)
AngioDynamics to Report Fiscal 2015 First Quarter Financial Results
GlobeNewswire - Thu Sep 25, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 first quarter ended August 31, 2014, on Thursday, October 9, 2014, after the close of the U.S. financial markets.
ANGO: 16.09 (+0.49)
Downtrend Call Working As Angiodynamics Stock Falls 9.1% (ANGO)
Comtex SmarTrend(R) - Mon Sep 22, 5:20PM CDT
SmarTrend identified a Downtrend for Angiodynamics (NASDAQ:ANGO) on July 9th, 2014 at $14.78. In approximately 3 months, Angiodynamics has returned 9.13% as of today's recent price of $13.43.
ANGO: 16.09 (+0.49)
ENSG, LAZ, EPAX, PTP, CUK, ANGO Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 09, 4:25AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Ensign Group Inc (NASDAQ:ENSG), Lazard Ltd (NYSE:LAZ), Ambassadors Group Inc (NASDAQ:EPAX), Petrichor Energy Inc (NYSE
ENSG: 35.00 (+0.40), CUK: 38.01 (+1.69), LAZ: 49.19 (+1.44), EPAX: 3.41 (+0.01), ANGO: 16.09 (+0.49), PTP: 61.18 (+1.07)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into AngioDynamics Inc. Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Wed Sep 03, 5:10PM CDT
Levi & Korsinsky, LLP is investigating AngioDynamics Inc. (NasdaqGS: ANGO) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
ANGO: 16.09 (+0.49)
AngioDynamics to Present at Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Thu Aug 07, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity 34 Annual Growth Conference on Thursday, August 14, 2014, at 8 a.m. (ET). The conference will be held at the InterContinental Hotel in Boston.
ANGO: 16.09 (+0.49)
AngioDynamics (ANGO) Crumbles: Stock Falls 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:41AM CDT
AngioDynamics (ANGO) fell over 7% in the last trading session amid huge volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.
SIRO: 78.38 (+1.47), BONE: 4.28 (+0.20), TMO: 118.22 (+3.89), ANGO: 16.09 (+0.49)